Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Altria Group    MO

ALTRIA GROUP

(MO)
  Report
Delayed Quote. Delayed Nyse - 01/24 04:04:38 pm
50.25 USD   -0.61%
01/24Bargain hunters fire up rally in cannabis stocks
RE
01/18ALTRIA : Deal for Stake In Juul Is Stuck In Antitrust Review
DJ
01/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Continues Investigating Altria Group, Inc.'s Directors and Officers for Breach of Fiduciary Duties – MO

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/25/2019 | 03:49pm EST

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues investigating certain directors and officers of Altria Group, Inc. (“Altria”) (NYSE: MO) for breaching their fiduciary duties to Altria and its shareholders. If you are an Altria shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or jpettigrew@scott-scott.com.

On December 20, 2018, Altria announced it acquired a 35% stake in JUUL Labs, Inc. (“JUUL”), the leading U.S. e-cigarette producer.

Scott+Scott is investigating whether the Board failed to disclose that: (1) Altria conducted insufficient due diligence before investing in JUUL; (2) Altria did not account for material risks associated with JUUL’s products and marketing practices; (3) the above, plus public scrutiny and governmental pressure on e-vapor products, made it likely that Altria’s investment in JUUL would materially harm Altria’s reputation and operations; and (4) as a result, Altria’s public statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On April 3, 2019, the U.S. Food and Drug Administration announced an investigation into 35 cases of people suffering seizures after “vaping.” On August 29, 2019, the Wall Street Journal reported that the U.S. Federal Trade Commission was investigating whether JUUL used marketing practices to appeal e-cigarettes to minors. Several other federal and state investigations into health risks of vaping, as well as JUUL’s marketing practices, are ongoing.

On September 25, 2019, Altria announced that Philip Morris International Inc. had called off a reported $200 billion merger with Altria, reportedly due to increasing scrutiny of vaping and Altria’s 35% stake in JUUL.

What You Can Do

If you are an Altria shareholder, you may have legal claims against Altria’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALTRIA GROUP
01/24Bargain hunters fire up rally in cannabis stocks
RE
01/18ALTRIA : Deal for Stake In Juul Is Stuck In Antitrust Review
DJ
01/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/17ALTRIA : Juul Deal Is Stuck in Antitrust Review
DJ
01/16ALTRIA : to Host Webcast of 2019 Fourth-Quarter and Full-Year Results
BU
01/06TSX rises 0.23% to 17,105.47
RE
More news
Financials (USD)
Sales 2019 19 873 M
EBIT 2019 10 604 M
Net income 2019 5 140 M
Debt 2019 27 385 M
Yield 2019 6,50%
P/E ratio 2019 22,3x
P/E ratio 2020 11,6x
EV / Sales2019 6,10x
EV / Sales2020 5,97x
Capitalization 93 873 M
Chart ALTRIA GROUP
Duration : Period :
Altria Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALTRIA GROUP
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 54,97  $
Last Close Price 50,25  $
Spread / Highest target 35,3%
Spread / Average Target 9,39%
Spread / Lowest Target -12,4%
EPS Revisions
Managers
NameTitle
Howard A. Willard Chairman, CEO, COO & Executive Vice President
William F. Gifford Vice Chairman & Chief Financial Officer
George Muñoz Independent Director
Thomas F. Farrell Independent Director
Dinyar S. Devitre Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALTRIA GROUP0.68%93 873
ITC LIMITED0.08%41 033
JAPAN TOBACCO INC.-2.21%38 055
HANJAYA MANDALA SAMPOERNA TBK PT--.--%18 462
KT&G CORP--.--%10 099
GUDANG GARAM TBK PT--.--%8 243